indications for glp-1 agonists The and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1 Drugs: Where We Are
Description
Docusate sodium (Colace) coats the stool itself
Approved for chronic weight management in adults with obesity or weight-related conditions
55 In regard to their safety profile, small molecule GLP-1 RAs have also shown similar side effects, being the gastrointestinal symptoms such as nausea, vomiting, and diarrhea the most commonly presented
A major concern with GLP-1RAs, despite their potent anti-obesity effects, is post-treatment weight rebound [16]
Patients should be aware of the signs to watch for, such as nausea, vomiting, and abdominal pain, which may necessitate a reassessment of their treatment plan
